These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12635675)

  • 1. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
    Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
    Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
    Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
    Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
    Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
    Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
    Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of traumatic hyphema with topical epsilon-aminocaproic acid.
    Goldberg MF
    Arch Ophthalmol; 1997 Sep; 115(9):1189-90. PubMed ID: 9298063
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model.
    Allingham RR; Crouch ER; Williams PB; Catlin JC; Loewy DM; Jacobson J
    Arch Ophthalmol; 1988 Oct; 106(10):1436-8. PubMed ID: 3178555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
    Derakhshan A; Firoozi J; Esmaeili S; Bakhtiari E; Abbaspour M; Abrishami M; Zia MJ
    J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of risk for secondary hemorrhage in traumatic hyphema.
    Rahmani B; Jahadi HR; Rajaeefard A
    Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema.
    McGetrick JJ; Jampol LM; Goldberg MF; Frenkel M; Fiscella RG
    Arch Ophthalmol; 1983 Jul; 101(7):1031-3. PubMed ID: 6870623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001).
    Romano PE; Robinson JA
    Binocul Vis Strabismus Q; 2000; 15(2):175-86. PubMed ID: 10893461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid in the treatment of pediatric traumatic hyphema.
    Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
    Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traumatic hyphema: outcomes of outpatient management.
    Shiuey Y; Lucarelli MJ
    Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminocaproic acid prophylaxis in traumatic hyphema.
    Wilson TW; Jeffers JB; Nelson LB
    Ophthalmic Surg; 1990 Nov; 21(11):807-9. PubMed ID: 2270168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Frenkel M
    Am J Ophthalmol; 1976 Mar; 81(3):355-60. PubMed ID: 769560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is topical corticosteroid necessary in traumatic hyphema?
    Türkoğlu EB; Celik T; Celik E; Ozkan N; Bursalı O; Coşkun SB; Alagoz G
    J Fr Ophtalmol; 2014 Oct; 37(8):613-7. PubMed ID: 25199483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
    Beiran I; Talmon T; Miller B
    Isr Med Assoc J; 2002 Nov; 4(11):1009-10. PubMed ID: 12489492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting therapeutic concentration of topical aminocaproic acid in traumatic hyphema.
    Ehlers WH; Crouch ER; Williams PB; Riggs PK
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2389-94. PubMed ID: 2243004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber].
    Kotas R; Neumann D; Ashkenazi I
    Harefuah; 1990 Nov; 119(9):269-70. PubMed ID: 2258114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient management of traumatic hyphemas in children.
    Coats DK; Viestenz A; Paysse EA; Plager DA
    Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.